Latest News about HALO
Recent news which mentions HALO
Here's How Much $100 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth Today
June 12, 2025
From Benzinga
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 5 Years
June 04, 2025
From Benzinga
Price Over Earnings Overview: Halozyme Therapeutics
May 28, 2025
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
May 24, 2025
From Benzinga
Evolv Technologies, Quantum Computing, ACADIA Pharmaceuticals And Other Big Stocks Moving Higher On Friday
May 16, 2025
From Benzinga
From Benzinga
S&P 500 Breaks Into Positive Territory For 2025
May 13, 2025
From TalkMarkets
Crude Oil Gains 3%; US Inflation Eases In April
May 13, 2025
From Benzinga
From Benzinga
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
May 09, 2025
From Benzinga
From Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
From Benzinga
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 5 Years
April 22, 2025
From Benzinga
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
April 11, 2025
From Benzinga
Peering Into Halozyme Therapeutics's Recent Short Interest
April 11, 2025
Tickers
HALO
From Benzinga
Assessing Halozyme Therapeutics: Insights From 9 Financial Analysts
February 20, 2025
Tickers
HALO
From Benzinga
Earnings Scheduled For February 18, 2025
February 18, 2025
From Benzinga
Demystifying Halozyme Therapeutics: Insights From 8 Analyst Reviews
February 04, 2025
Tickers
HALO
From Benzinga
9 Analysts Have This To Say About Halozyme Therapeutics
December 18, 2024
Tickers
HALO
From Benzinga
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
December 11, 2024
Tickers
HALO
From Benzinga
From Benzinga
Breaking Down Halozyme Therapeutics: 10 Analysts Share Their Views
November 20, 2024
Tickers
HALO
From Benzinga
Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
November 15, 2024
From Benzinga
Looking Into Halozyme Therapeutics's Recent Short Interest
November 05, 2024
Tickers
HALO
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.